Michael's Investment Perspective:
Navigating Wealth, Risk, and Life’s Lessons

Bristol Myers Squibb (BMY), a prominent global biopharmaceutical company, currently trades at a price of $50.68. This analysis aims to determine whether BMY represents a favorable investment opportunity at this valuation by examining its fundamental strengths, technical indicators, and the prevailing macroeconomic environment. This assessment will delve into recent news and analyst sentiment, the company's financial health and drug pipeline, insights from moving averages and Fibonacci retracement levels, and the impact of recent stock market dynamics and the strength of the US dollar. Bristol Myers Squibb: A Snapshot of Fundamentals Recent developments and analyst perspectives provide a mixed view of Bristol Myers Squibb. While the company experienced a setback with the Phase 3 ODYSSEY-HCM trial for Camzyos failing to meet its primary endpoints , which subsequently led to a decrease in the stock price , there have been notable successes. The U.S. Food and Drug Administration (FDA) ...

For decades, UPS and FedEx were untouchable titans in the shipping world — dependable, dominant, and dividend-paying. But the market landscape is shifting rapidly, and what once looked like an impenetrable moat is starting to resemble a dry riverbed . As a UPS shareholder, I’ve always admired the brand’s consistency. But lately, admiration has turned into concern. Not because the trucks stopped running — but because they’re running emptier routes in a world that’s quickly moving on from their services. Amazon Has Outgrown the Competition What started as an online bookstore is now a logistics monster . Amazon has built its own shipping empire, from Sprinter vans to cargo planes , cutting the need for outside help. In fact, it’s been reported that Amazon delivers more packages annually in the U.S. than FedEx — and is closing the gap with UPS. Every package Amazon delivers themselves is money UPS and FedEx don't earn . And it’s not just cost-saving. It’s about total control ...